Skip to main content
main-content

18.10.2017 | Review Article | Sonderheft 1/2018

Indian Journal of Thoracic and Cardiovascular Surgery 1/2018

Non-invasive approaches for lung cancer diagnosis

Zeitschrift:
Indian Journal of Thoracic and Cardiovascular Surgery > Sonderheft 1/2018
Autoren:
Aditi Mehta, Guillermo Barreto

Abstract

Lung cancer is the leading cause of cancer-related deaths worldwide. The case-fatality rate of lung cancer remains exceptionally high at 95% despite numerous medical advancements in therapeutic strategies in the last decades. However, patients diagnosed at Stage I are commonly curable and have a 5-year survival rate of 50–80%. Unfortunately, delayed diagnosis of lung cancer has been unavoidable and is an important factor in the overall outcome of treatment. Accordingly, screening of high-risk individuals is likely to have hugely beneficial outcomes for patient survival. Current screening approaches include low-dose computed tomography and chest X-ray. Recently, alternative approaches for lung cancer screening have been developed including analysis of biomarkers, including DNA, RNA, proteins, and antibodies in blood, sputum, bronchoalveolar lavage (BAL), and breath. Biomarker analysis would also provide critical information regarding tumor growth pattern, cells of origin of tumor, subtype of lung cancer, and/or drug metabolism as well as monitor patient prognosis. Novel non-invasive lung cancer diagnostic strategies could improve and complement the success of CT-scan and chest X-ray.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Sonderheft 1/2018

Indian Journal of Thoracic and Cardiovascular Surgery 1/2018 Zur Ausgabe
  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise